Clonogenic assays measure leukemia stem cell killing not detectable by chromium release and flow cytometric cytotoxicity assays

References

• Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, . A cell initiating human myeloid leukemia after transplantation into SCID mice. Nature. 1994;367; 645–8.
   PubMed Web of Science ®Google Scholar
• Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730–7.
   PubMed Web of Science ®Google Scholar
• Al Hajj M, Wicha MS, Benito-Hernandez A, Morrision SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100:3983–8.
   PubMed Web of Science ®Google Scholar
• Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB. Cancer Res. 2003;63:5821–8.
   PubMed Web of Science ®Google Scholar
• Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, . Identification of human brain tumour initiating cells. Nature. 2004;432:396–401.
   PubMed Web of Science ®Google Scholar
• Ricci-Vitiani L, Lobardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R. Identification and expansion of human colon cancer-initiating cells. Nature. 2007; 445:111–15.
   PubMed Web of Science ®Google Scholar
• O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;45:106–10.
   Google Scholar
• Matsui W, Huff CA, Wang Q, Malehorn MT, Barber J, Tanhehco Y, . Characterization of clonogenic multiple myeloma cells. Blood. 2004;103:2332–6.
   PubMed Web of Science ®Google Scholar
• Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA. 2004;101:781–6.
   PubMed Web of Science ®Google Scholar
• Gong J, Maki G, Klingemann H-G. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia. 1994:8;652–8.
   PubMed Web of Science ®Google Scholar
• Yan Y, Steinherz P, Klingemann H-G, Dennig D, Childs BH, McGuirk J, . Antileukemia activity of a natural killer cell line against human leukemias. Clin Cancer Res. 1998;4: 2859–68.
   PubMed Web of Science ®Google Scholar
• Aria S, Meagher R, Swearingen M, Myint H, Rich E, Martinson J, Klingemann H. Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial. Cytotherapy. 2008;10:625–32.
   PubMedGoogle Scholar
• Costello RT, Mallet F, Gaugle B, Sainty D, Arnoulet C, . Human acute myeloid leukaemia CD34+/CD38− progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Cancer Res. 2000;60:4403–11.
   PubMed Web of Science ®Google Scholar
• Jacobs P, Wood L. Clonogenic growth patterns correlate with chemotherapy response in acute myeloid leukaemia. Hematology. 2005;10:321–6.
   PubMed Web of Science ®Google Scholar
• Curtis JE, Minden MD, Minkin S, McCulloch EA. Sensitivities of AML blast stem cells to idarubicin and daunorubicin: a comparison with normal hematopoietic progenitors. Leukemia. 1995;9:396–404.
   PubMed Web of Science ®Google Scholar
• Curtis DJ, Metcalf D, Alexander B, Begley CG. Leukemic cells from murine myeloid leukemia display an intrinsic ability for autonomous proliferation. Exp Hematol. 2000; 28:36–45.
   PubMed Web of Science ®Google Scholar
• Suck G, Branch DR, Smyth MJ, Miller RG, Vergidis J, Fahim S, Keating A. KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity. Exp Hematol. 2005;33:1160–71.
   PubMed Web of Science ®Google Scholar
• Taussig DC, Miraki-Moud F, Anjos-Afonso F, Pearce DJ, Allen K, Ridler C, . Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood. 2008;112: 568–75.
   PubMed Web of Science ®Google Scholar
• Brunner KT, Mauel J, Cerottini JC, Chapus B. Quantitative assay of the lytic action of immune lymphoid cells on 51Cr-labelled allogenic target cells in vitro; inhibition by isoantibodies and by drugs. Immunology. 1968;14:181–96.
   PubMed Web of Science ®Google Scholar
• Ozdemir O, Ravindranath Y, Savasan S. Cell-mediated cytotoxicity evaluation using monoclonal antibody staining for target or effector cells with annexin V/propridium iodide colabeling by fluorosphere-adjusted counts on three-color flow cytometery. Cytometry. 2003;56A;53–60.
   Google Scholar